CLPT ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (CLPT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 92% planned / 8% discretionary
Largest single sale: $1.1M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH | CEO and President | Sell 10b5-1 | 20,000 | $19.38 | $387.6K | 116,842 −14.6% of holding | |
| BURNETT JOSEPH 2 fills | CEO and President | Sell 10b5-1 | 61,843 | $17.79 | $1.1M | 191,388 −24.4% of holding | |
| Richards Timothy T. | Director | Sell | 5,415 | $12.17 | $65.9K | 87,198 −5.8% of holding | |
| Klein Matthew B. | Director | Sell | 16,000 | $11.59 | $185.4K | 46,935 −25.4% of holding | |
| FALLON LYNNETTE C | Director | Sell 10b5-1 | 5,091 | $11.14 | $56.7K | 48,227 −9.5% of holding | |
| BURNETT JOSEPH | CEO and President | Sell 10b5-1 | 19,951 | $15.17 | $302.7K | 193,231 −9.4% of holding | |
| BURNETT JOSEPH | CEO and President | Sell 10b5-1 | 2,943 | $15.57 | $45.8K | 214,116 −1.4% of holding | |
| BURNETT JOSEPH | CEO and President | Sell 10b5-1 | 20,000 | $16.12 | $322.4K | 11,565 −63.4% of holding | |
| BURNETT JOSEPH 4 fills | CEO and President | Sell 10b5-1 | 26,463 | $26.98 | $714.0K | 225,939 −10.5% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.